DUBLIN–(BUSINESS WIRE)–The “Epilepsy Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering.
The report predicts the global epilepsy drug market to grow with a CAGR of 7.1% over the forecast period from 2019-2025.
The report on the global epilepsy drug market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on epilepsy drug market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
The report on epilepsy drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global epilepsy drug market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global epilepsy drug market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Growing prevalence’s of neurological disorders and rising occurrences of epilepsy
2) Restraints
- Less awareness regarding epilepsy drug in middle-income economies
3) Opportunities
- Growing awareness about epilepsy among the people and increasing government funding, drugs reimbursement option
Key Topics Covered:
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Epilepsy Drug Market Highlights
2.2. Epilepsy Drug Market Projection
2.3. Epilepsy Drug Market Regional Highlights
3. Global Epilepsy Drug Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product Type
3.4.2. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Epilepsy Drug Market
4. Epilepsy Drug Market Macro Indicator Analysis
5. Global Epilepsy Drug Market by Product Type
5.1. First-generation Drugs
5.1.1 Phenytoin
5.1.2 Oxcarbazepine
5.1.3 Ethosuximide
5.1.4 Others
5.2. Second-generation Drugs
5.2.1 Felbamate
5.2.2 Lamotrigine
5.2.3 Topiramate
5.2.4 Others
5.3. Third Generation Drugs
5.3.1 Lacosamide
5.3.2 Ralfinamide
5.3.3 Eslicarbazepine Acetate
5.3.4 Others
6. Global Epilepsy Drug Market by Region 2019-2025
6.1. North America
6.1.1. North America Epilepsy Drug Market by Product Type
6.1.2. North America Epilepsy Drug Market by Country
6.2. Europe
6.3. Asia-Pacific
6.4. RoW
7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Epilepsy Drug Market
7.2. Companies Profiles
7.2.1. Teva Pharmaceutical Industries
7.2.2. Sunovion Pharmaceuticals, Inc.,
7.2.3. GlaxoSmithKline plc
7.2.4. Abbott Laboratories
7.2.5. Sanofi S.A.
7.2.6. Novartis International AG
7.2.7. Eisai Co., Ltd.
7.2.8. Pfizer Inc.
7.2.9. UCB S.A.
7.2.10. Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/r/lv8g31
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs